Chongqing Zhifei Biological Products Co., Ltd.: Coronavirus Infections trials
The registry lists 10 Coronavirus Infections studies with Chongqing Zhifei Biological Products Co., Ltd. as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 2Phase 3 2No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)Not yet recruitingNCT06025812Not applicable
- Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)CompletedNCT05850507Not applicable
- Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)Status unknownNCT05128643Phase 3
- Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)CompletedNCT05109598Phase 2
- Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)Status unknownNCT05091411Phase 3
- Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing ImmunityCompletedNCT05089045Not applicable
- Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)CompletedNCT04961359Phase 1
- Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)Status unknownNCT04550351Phase 1
- Clinical Study of Recombinant Novel Coronavirus VaccineStatus unknownNCT04466085Phase 2
- Phase I Clinical Study of Recombinant Novel Coronavirus VaccineStatus unknownNCT04445194Phase 1